Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1β in volume-overloaded rats with heart failure

Journal of Geriatric Cardiology

Volumn 9, Issue 2, 2012, Pages 172-179

  Wang, Xue Hui ^a,b   Zhuo, Xiao Zhen ^a   Ni, Ya Juan ^a   Gong, Min ^a   Wang, Ting Zhong ^a   Lu, Qun ^a   Ma, Ai Qun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac function; Connexin 43; Gap junction; Heart failure; Neuregulin 1 ; Remodeling

Indexed keywords

CONNEXIN 43; NEU DIFFERENTIATION FACTOR; PROTEIN NEUREGULIN 1BETA; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GAP JUNCTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84866238920     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2012.03271     Document Type: Article

References (41)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 17: E25-E146.
2. Britsch S. The neuregulin-I/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol 2007; 190: 1-65.
3. Freedman NJ, Ginsburg GS. Novel - and "Neu" - Therapeutic possibilities for heart failure. J Am Coll Cardiol 2006; 48: 1448-1450.
4. Lemmens K, Doggen K, De Keulenaer GW. Role of neuregulin-1/ ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 2007; 116: 954-960. (Pubitemid 47300920)
5. Negro A, Brar BK, Lee KF. Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog Horm Res 2004; 59: 1-12. (Pubitemid 41327144)
6. Liu FF, Stone JR, Schuldt AJ, et al. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J PhysiolHeart Circ Physiol 2005; 289: H660-H666. (Pubitemid 41129381)
7. Lee KF, Simon H, Chen H, et al. Requirement for neu- regulin receptor erbB2 in neural and cardiac development. Nature 1995; 378: 394-398.
8. Gutstein DE, Morley GE, Vaidya D, et al. Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 2001; 104: 1194-1199. (Pubitemid 32830407)
9. Akar FG, Nass RD, Hahn S, et al. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am J Physiol Heart Circ Physiol 2007; 293: H1223-H1230. (Pubitemid 47254225)
10. Akar FG, Spragg DD, Tunin RS, et al. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 2004; 95: 717-725. (Pubitemid 39331932)
11. Esperanza A, Marisol RM, Rio A, et al. Cx43 deficiency is associated with dilated cardiomyopathy in old mice that can be rescued by genetic ablation of its c-terminal domain [Abstract]. Circulation 2011; 124: A12556.
12. Liu Y, Huang H, Xia WF, et al. Inhibition of NADPH oxidase up-regulates connexin 43 and ameliorates electrical remodeling in rabbits with heart failure. Biomed Pharmacother 2011; 1: 33-38.
13. Iravanian S, Sovari AA, Lardin HA, et al. Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43. J Mol Med 2011; 89: 677-687.
14. Kuramochi Y, Guo X, Sawyer DB. Neuregulin activates erbB2- dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol 2006; 41: 228-235. (Pubitemid 44080212)
15. Garcia R, Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 1990; 24: 430-432. (Pubitemid 20179596)
16. Isenberg G, Klockner U. Calcium tolerant ventricular myocytes prepared by preincubation in a "KB" medium. Pflugers Arch 1982; 395: 6-18. (Pubitemid 13236181)
17. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation 2006; 113: 1424-1433. (Pubitemid 43739439)
18. Liu X, Gu X, Li Z, et al. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 2006; 48: 1438-1447. (Pubitemid 44436803)
19. Fukazawa R, Miller TA, Kuramochi Y, et al. Neuregulin-1 protects ventricular myocytes from anthracycline -induced apoptosis via erbB4-dependent activation of P13-kinase/Akt. J Mol Cell Card 2003; 35: 1473-1479. (Pubitemid 37491190)
20. Jabbour A, Hayward CS, Keogh AM, et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 2011; 13: 83-92.
21. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-2368. (Pubitemid 50011582)
22. Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 2006; 175: 611-617. (Pubitemid 44439724)
23. Kmecova J, Klimas J. Heart rate correction of the QT duration in rats. Eur J Pharmacol 2010; 641: 187-192.
24. Davey P. QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function. Eur J Heart Fail 2000; 2: 265-271. (Pubitemid 30670725)
25. Xie RQ, Cui W, Liu F, et al. Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure. Int J Cardiol 2010; 140: 255-257.
26. Kirchhoff S, Kim JS, Hagendorff A, et al. Abnormal cardiac conduction and morphogenesis in Connexin40 and Connexin43 double-deficient mice. Circ Res 2000; 87: 399-405.
27. Hesketh GG, Shah MH, Halperin VL, et al. Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res 2010; 106: 1153-1163.
28. Sawyer DB, Zuppinger C, Miller TA, et al. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1β and Anti-erbB2. Circulation 2002; 205: 1551-1554.
29. Sawyer DB. Oxidative stress in heart failure: What are we missing? Am J Med Sci 2011; 342: 120-124.
30. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996; 28: 506-514. (Pubitemid 26274350)
31. Siwik DA, Tzortzis JD, Pimental DR, et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, anapoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999; 85: 147-153. (Pubitemid 29343313)
32. Brero A, Ramella R, Fitou A, et al. Neuregulin-1β rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes. Cardiovasc Res 2010; 88: 443-452.
33. Giraud, MN, Fluck M, Zuppinger C, et al. Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1β. J Appl Physiol 2005; 99: 313-322. (Pubitemid 40934497)
34. Poelzing S, Rosenbaum DS. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H1762-H1770. (Pubitemid 39313284)
35. Peters NS, Green CR, Wilson PA, et al. Reduced content of connexin43 gap junction in ventricular myocardium from hypertrophied and ischaemic human hearts. Circulation 1993; 88: 864-871.
36. Severs NJ, Bruce AF, Dupont E, et al. Remodeling of gap junctions and connexin expression in diseased myoeardium. Cardiovase Res 2008; 80: 9-19.
37. Lemmens K, Segers VF, Demolder M, et al. Role of neuregulin-1/ERBB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem 2006; 28: 19469-19477. (Pubitemid 44035451)
38. Timolati F, Ott D, Pentassuglia L, et al. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. J Mol Cell Cardiol 2006; 41: 845-854. (Pubitemid 44635571)
39. 2: regulation of reactive oxygen species levels by PI3K. J Biol Chem 2001; 49: 6379-46385.
40. Feng QP, Song W, Lu XR, et al. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002; 106: 873-879.
41. Lemmens K, Fransen P, Sys SU, et al. Neuregulin-1 induces a negative inotropic effect in cardiac muscle:role of nitric oxide synthase. Circulation 2004; 109: 324-326. (Pubitemid 38133898)